COMMUNIQUÉS West-GlobeNewswire

ViroMissile Appoints Diane Simeone, M.D., and Matt Mulvey, Ph.D. as Advisors
08/10/2026
Appointments add scientific, clinical, and business depth as three Phase 1 intravenously-dosed oncolytic viral programs advance in the clinic SAN DIEGO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ViroMissile, Inc., a cancer [...]
Spirair Announces Publication of Multicenter Study Demonstrating Significant Six-Month Improvements with SeptAlign
08/10/2026
Six-month Vayu Study results published in Laryngoscope Investigative Otolaryngology 63 percent reduction in NOSE scores One-day median return to work 97 percent of patients would recommend the procedure to friends or [...]
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
08/10/2026
Advancing Precision Oncology and Partner-Ready Therapeutic Programs Through Capital-Efficient Development PHILADELPHIA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), [...]
Enovis to Host Third Quarter 2026 Results Conference Call on November 5th
08/10/2026
Dallas, TX, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to [...]
Phathom Pharmaceuticals to Present New Data and Analyses for VOQUEZNA® (vonoprazan) at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting
08/10/2026
Three scientific presentations will highlight new analyses of VOQUEZNA ® (vonoprazan) in GERD, including real-world patient characteristics, efficacy across BMI subgroups, and cost-effectiveness in Erosive Esophagitis [...]
Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting
08/10/2026
TEL AVIV, Israel, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that an additional presentation highlighting [...]
MMI Raises $125M in Series D to Accelerate Commercial Growth of the Symani Surgical System Worldwide
08/10/2026
Financing will support market expansion, expand access, and advance the clinical evidence needed to broaden the role of robotic microsurgery JACKSONVILLE, Fla., Oct. 08, 2026 (GLOBE NEWSWIRE) -- MMI (Medical [...]
Amneal to Report Third Quarter 2026 Results on November 3, 2026
08/10/2026
BRIDGEWATER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced it will report third quarter 2026 financial results on Tuesday, November 3, [...]
Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors
08/10/2026
Brings more than 25 years of experience in clinical strategy, biostatistics and regulatory submissions from Abivax, Alumis, MyoKardia and Genentech/Roche SAN DIEGO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Aardvark [...]
TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Revenue of $2.5 Million, Up 27% Year-Over-Year
08/10/2026
Recognized sales and the full open order book together total $9 million; $1.7 million booked for the fourth quarter FREDERICK, Md., Oct. 08, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a [...]
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026
08/10/2026
ZUG, Switzerland and BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that clinical data from the Phase 1b trial of CTX310 ® , its investigational CRISPR/Cas9 in vivo gene [...]
CytoDyn to Present Updated Data from Phase 2 CLOVER Clinical Study at ESMO Congress 2026
08/10/2026
VANCOUVER, Washington, Oct. 08, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody [...]
Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing
08/10/2026
Company remains focused on its transition toward commercial revenue generation and the advancement of its U.S. clinical programs HOUSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “ [...]
Retrieve Medical Announces National Distribution Agreement for Retrieve Passport
08/10/2026
Agreement with a leading U.S. financial services and membership platform establishes a major new consumer distribution channel. BEDMINSTER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC: [...]
SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform
08/10/2026
New platform to be launched with managers from Millennium Management, Balyasny and Citadel, designed to enable the next generation of proprietary traders under Eric Jackson’s leadership NORTH PALM BEACH, Fla., Oct. 08, [...]
Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model
08/10/2026
Second-generation oral mucosal vaccine candidate (VXA-H5-02) induced robust cross-neutralizing antibodies, significantly reduced viral load, and completely protected against lethal clade 2.3.4.4b viral challenge SOUTH [...]
IMUNON to Participate in Upcoming Investor Conferences
08/10/2026
LAWRENCEVILLE, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology company developing DNA-mediated immunotherapies, today announced that Stacy Lindborg, Ph.D., President [...]
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
08/10/2026
SALT LAKE CITY and BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine and SOPHiA GENETICS (NASDAQ: SOPH) today announce a [...]
Privia Health to Report Third Quarter 2026 Results on Thursday, November 5
08/10/2026
ARLINGTON, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its third-quarter and nine-month periods ended September 30, [...]

Pages